Sanofi/GSK vaccine delay a bitter blow for world’s poorest countries - Oxfam 11 December, 2020 - 17:10
Country: World Source: Oxfam
Responding to today’s announcement that the Sanofi/GSK vaccine will not be ready until the end of 2021, Oxfam’s Global Health and Gender Equality Officer, Julia Heres Garcia said:
“The delay is a bitter blow for poorer nations given Sanofi-GSK was set to provide nearly one third of COVAX doses – the global vaccine purchasing facility upon which many of the poorest countries depend.
“Even without this delay COVAX had only secured enough doses to vaccinate 1 in 10 people in many of the poorest countries by the end of next year, while rich countries had enough to vaccinate their entire populations nearly 3 times over.
Sanofi/GSK vaccine delay a bitter blow for world’s poorest countries - Oxfam
Format
11 Dec 2020
Responding to today’s announcement that the Sanofi/GSK vaccine will not be ready until the end of 2021, Oxfam’s Global Health and Gender Equality Officer, Julia Heres Garcia said:
“The delay is a bitter blow for poorer nations given Sanofi-GSK was set to provide nearly one third of COVAX doses – the global vaccine purchasing facility upon which many of the poorest countries depend.
“Even without this delay COVAX had only secured enough doses to vaccinate 1 in 10 people in many of the poorest countries by the end of next year, while rich countries had enough to vaccinate their entire populations nearly 3 times over.